P1029: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PELABRESIB (CPI-0610) IN COMBINATION WITH RUXOLITINIB VS RUXOLITINIB OR FEDRATINIB MONOTHERAPY IN PATIENTS WITH INTERMEDIATE OR HIGH-RISK MYELOFIBROSIS

Bibliographic Details
Main Authors:	V. Gupta, J. Mascarenhas, M. Kremyanskaya, R. K. Rampal, M. Talpaz, J.-J. Kiladjian, A. Vannucchi, S. Verstovsek, G. Colak, D. Dey, C. Harrison
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000846984.81563.96

Internet